Ocumension Therapeutics 13D and 13G filings for Alimera Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-04-30 1:16 pm Purchase |
2021-04-16 | 13G | Alimera Sciences, Inc. ALIM |
Ocumension Therapeutics | 1,144,945 16.620% |
1,144,945 (New Position) |
Filing |